Aoife S. Reilly
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Peripheral defects precede neuromuscular pathology in the Smn2B/- mouse model of spinal muscular atrophy.
Journal: Journal of neuromuscular diseases
Published: February 20, 2025
Liver SMN restoration rescues the Smn2B/- mouse model of spinal muscular atrophy.
Journal: EBioMedicine
Published: May 14, 2024
Long term peripheral AAV9-SMN gene therapy promotes survival in a mouse model of spinal muscular atrophy.
Journal: Human molecular genetics
Published: August 31, 2023
Base editing as a genetic treatment for spinal muscular atrophy.
Journal: bioRxiv : the preprint server for biology
Published: January 30, 2023
Optimization of base editors for the functional correction of SMN2 as a treatment for spinal muscular atrophy.
Journal: Nature biomedical engineering
Published: January 21, 2023
Disparities in Decompressive Cranial Surgery Utilization in Severe Traumatic Brain Injury Patients without a Primary Extra-Axial Hematoma: A U.S. Nationwide Study.
Journal: World neurosurgery
Published: June 17, 2022
Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophy.
Journal: Gene therapy
Published: January 21, 2022
Venous Thromboembolism Risk and Outcomes Following Decompressive Craniectomy in Severe Traumatic Brain Injury: An Analysis of the Nationwide Inpatient Sample Database.
Journal: World neurosurgery
Published: December 01, 2021
Applying rigorous eligibility criteria to studies evaluating prognostic utility of serum biomarkers in pulmonary embolism: A systematic review and meta-analysis.
Journal: Thrombosis research
Published: May 01, 2020
Regarding the necessity of an updated meta-analysis on the prognostic value of serum biomarkers in patients with pulmonary embolism.
Journal: Thrombosis research
Published: December 11, 2018
Last Updated: 09/26/2026